HHH
HCW Biologics Inc.
No trades
No trades
Price target
8.000.000.00%
The 1 analyst offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of HCWB is 1.23 USD — it has decreased by −7.14% in the past 24 hours. Watch HCW Biologics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange HCW Biologics Inc. stocks are traded under the ticker HCWB.
HCWB stock has fallen by −24.52% compared to the previous week, the month change is a −47.77% fall, over the last year HCW Biologics Inc. has showed a −95.40% decrease.
We've gathered analysts' opinions on HCW Biologics Inc. future price: according to them, HCWB price has a max estimate of 8.00 USD and a min estimate of 8.00 USD. Watch HCWB chart and read a more detailed HCW Biologics Inc. stock forecast: see what analysts think of HCW Biologics Inc. and suggest that you do with its stocks.
HCWB reached its all-time high on Jul 20, 2021 with the price of 1,866.00 USD, and its all-time low was 1.14 USD and was reached on Oct 14, 2026. View more price dynamics on HCWB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HCWB stock is 11.26% volatile and has beta coefficient of 3.17. Track HCW Biologics Inc. stock price on the chart and check out the list of the most volatile stocks — is HCW Biologics Inc. there?
Today HCW Biologics Inc. has the market capitalization of 2.62 M, it has decreased by −8.19% over the last week.
Yes, you can track HCW Biologics Inc. financials in yearly and quarterly reports right on TradingView.
HCW Biologics Inc. is going to release the next earnings report on Nov 12, 2026. Keep track of upcoming events with our Earnings Calendar.
HCWB earnings for the last quarter are −11.58 USD per share, whereas the estimation was −1.98 USD resulting in a −484.85% surprise. The estimated earnings for the next quarter are −1.35 USD per share. See more details about HCW Biologics Inc. earnings.
HCWB net income for the last quarter is −15.37 M USD, while the quarter before that showed 1.26 M USD of net income which accounts for 0.00% change. Track more HCW Biologics Inc. financial stats to get the full picture.
No, HCWB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 16, 2026, the company has 35 employees. See our rating of the largest employees — is HCW Biologics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HCW Biologics Inc. EBITDA is −5.45 M USD, and current EBITDA margin is −22.30 K%. See more stats in HCW Biologics Inc. financial statements.
Like other stocks, HCWB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HCW Biologics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HCW Biologics Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HCW Biologics Inc. stock shows the sell signal. See more of HCW Biologics Inc. technicals for a more comprehensive analysis.